OBI-992, a novel TROP2 targeting antibody-drug conjugate, displayed excellent antitumor efficacy in various animal models

被引：0
|
作者：
Li, Wan-Fen
Chiang, Ming-Feng
Weng, Hao-Cheng
Yang, Jhih-Jie
Wu, Hsin-Shan
Lin, Chun-Jung
Chiu, Ping-Tzu
Lai, Ming-Tain
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-1893
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1893
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A novel dual drug antibody-drug conjugate targeting hTrop2 has synergetic antitumor activity in solid tumor models
    Zhu, Jie
    Zhao, Xiaobei
    Li, Eileen
    Xu, Hong
    Nie, Lei
    Chen, Gang
    Wang, Haibing
    CANCER RESEARCH, 2024, 84 (06)
  • [22] ESG401, a novel Trop2 antibody-drug conjugate (ADC), and its efficacy evidence in HER2-negative metastatic breast cancer with brain metastases
    Ma, F.
    Qiu, F.
    Tong, Z.
    Wang, J.
    Shi, Y.
    Li, L.
    Yu, G.
    Shi, H.
    Wu, X.
    Liu, A.
    Zhang, Y.
    Wang, H.
    Cheng, Y.
    Yang, H.
    Li, H.
    Chang, J.
    Zhou, Q.
    ANNALS OF ONCOLOGY, 2024, 35 : S359 - S359
  • [23] Effective antitumor therapy based on a novel antibody-drug conjugate targeting the Tn carbohydrate antigen
    Sedlik, Christine
    Heitzmann, Adele
    Viel, Sophie
    Sarkouh, Rafik Ait
    Batisse, Cornelie
    Schmidt, Frederic
    De la Rochere, Philippe
    Amzallag, Nathalie
    Osinaga, Eduardo
    Oppezzo, Pablo
    Pritsch, Otto
    Sastre-Garau, Xavier
    Hubert, Pascale
    Amigorena, Sebastian
    Piaggio, Eliane
    ONCOIMMUNOLOGY, 2016, 5 (07):
  • [24] Generation of a novel Antibody-Drug Conjugate targeting endosialin: potent and durable antitumor response in sarcoma
    Capone, Emily
    Piccolo, Enza
    Fichera, Imma
    Ciufici, Paolo
    Barcaroli, Daniela
    Sala, Arturo
    De laurenzi, Vincenzo
    Iacobelli, Valentina
    Iacobelli, Stefano
    Sala, Gianluca
    ONCOTARGET, 2017, 8 (36) : 60368 - 60377
  • [25] Preclinical efficacy studies of DS-1062a, a novel TROP2-targeting antibody-drug conjugate with a novel DNA topoisomerase I inhibitor DXd.
    Okajima, Daisuke
    Yasuda, Satoru
    Yokouchi, Yusuke
    Fujitani, Tomomichi
    Sakurai, Ken
    Yamaguchi, Junko
    Kitamura, Michiko
    Terauchi, Tomoko
    Shibutani, Tomoko
    Aida, Tetsuo
    Nakada, Takashi
    Tokuhiro, Shinya
    Toki, Tadashi
    Noguchi, Yutaka
    Abe, Yuki
    Agatsuma, Toshinori
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [26] Datopotamab Deruxtecan, a Novel TROP2-directed Antibody-drug Conjugate, Demonstrates Potent Antitumor Activity by Efficient Drug Delivery to Tumor Cells
    Okajima, Daisuke
    Yasuda, Satoru
    Maejima, Takanori
    Karibe, Tsuyoshi
    Sakurai, Ken
    Aida, Tetsuo
    Toki, Tadashi
    Yamaguchi, Junko
    Kitamura, Michiko
    Kamei, Reiko
    Fujitani, Tomomichi
    Honda, Tomoyo
    Shibutani, Tomoko
    Muramatsu, Sumie
    Nakada, Takashi
    Goto, Riki
    Takahashi, Shu
    Yamaguchi, Miki
    Hamada, Hirofumi
    Noguchi, Yutaka
    Murakami, Masato
    Abe, Yuki
    Agatsuma, Toshinori
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12) : 2329 - 2340
  • [27] A novel SLC3A2-targeting antibody-drug conjugate exerts potent antitumor efficacy in head and neck squamous cell cancer
    Zheng, Meijun
    Wang, Zeng
    Li, Mengyao
    Yang, Nian
    Lu, Huaqing
    Zhang, Zongliang
    Dong, Yijun
    Chen, Yongdong
    Zhu, Zhixiong
    Tong, Aiping
    Yang, Hui
    TRANSLATIONAL ONCOLOGY, 2024, 45
  • [28] Antitumor Activity of a Pyrrolobenzodiazepine Antibody-Drug Conjugate Targeting LGR5 in Preclinical Models of Neuroblastoma
    Tu, Jianghua
    Toh, Yukimatsu
    Aldana, Adela M.
    Wen, Jake J.
    Wu, Ling
    Jacob, Joan
    Li, Li
    Pan, Sheng
    Carmon, Kendra S.
    Liu, Qingyun J.
    PHARMACEUTICS, 2024, 16 (07)
  • [29] BCG033, a novel bispecific antibody-drug conjugate targeting PTK7 and TROP2, demonstrates preclinical efficacy against triple-negative breast cancer and other solid tumor xenografts
    Yao, Sufei
    Shang, Chengzhang
    An, Gao
    Guo, Chaoshe
    An, W. Frk
    Yang, Yi
    CANCER RESEARCH, 2024, 84 (06)
  • [30] Discovery of BCG033, a novel anti-PTK7 x TROP2 bispecific antibody-drug conjugate with promising efficacy against triple-negative breast cancer
    Yao, Sufei
    Shang, Chengzhang
    An, Gao
    Zhang, Ellen
    Lin, Qingcong
    Yang, Yi
    CANCER RESEARCH, 2023, 83 (08)
12345